InvestSMART

Bionomics Limited (ASX: BNO) - Announcements

DELISTED - Current share price for BNO : $0.010

ASX company news and announcements for Bionomics Limited (BNO) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Bionomics Limited (BNO) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Bionomics Limited (BNO), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Bionomics Limited (BNO)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Bionomics Annual Report 2018 12 Oct 2018 3:51PM $0.190 $0.010 fallen by 94.74%
- Notice of Annual General Meeting/Proxy Form 12 Oct 2018 3:42PM $0.190 $0.010 fallen by 94.74%
- Change in substantial holding 5 Oct 2018 5:23PM $0.190 $0.010 fallen by 94.74%
- Bionomics' PTSD Trail Results Presentation 2 Oct 2018 10:49AM $0.165 $0.010 fallen by 93.94%
- Bionomics' PTSD Trial Results 2 Oct 2018 9:18AM $0.500 $0.010 fallen by 98%
- Trading Halt 28 Sep 2018 8:54AM $0.500 $0.010 fallen by 98%
- BNO to Host KOL Call on BNC210 and Treatment of Agitation 4 Sep 2018 9:59AM $0.460 $0.010 fallen by 97.83%
- Date of 2018 Annual General Meeting 31 Aug 2018 4:07PM $0.485 $0.010 fallen by 97.94%
- Appendix 3B 24 Aug 2018 3:40PM $0.480 $0.010 fallen by 97.92%
- Securities Trading Policy 17 Aug 2018 4:12PM $0.435 $0.010 fallen by 97.70%
- Full Year Statutory Accounts 16 Aug 2018 4:41PM $0.475 $0.010 fallen by 97.89%
- Bionomics 2017/2018 Preliminary Final Results 16 Aug 2018 4:37PM $0.475 $0.010 fallen by 97.89%
- Bionomics Presents at Annual Bioshares Biotech Summit 27 Jul 2018 10:07AM $0.485 $0.010 fallen by 97.94%
- Appendix 4C - quarterly 20 Jul 2018 2:48PM $0.485 $0.010 fallen by 97.94%
- End-of-Treatment Milestone Met in Phase 2 PTSD Trial 9 Jul 2018 10:07AM $0.525 $0.010 fallen by 98.10%
- Appendix 3B 2 Jul 2018 3:59PM n/a $0.010 n/a
- Bionomics NOW Newsletter June 2018 25 Jun 2018 10:00AM $0.510 $0.010 fallen by 98.04%
- Ceasing to be a substantial holder 15 Jun 2018 8:26AM $0.540 $0.010 fallen by 98.15%
- Appendix 3B 8 Jun 2018 3:39PM $0.565 $0.010 fallen by 98.23%
- Commencement of BNC210 Phase 2 Agitation Trial 23 May 2018 9:37AM $0.555 $0.010 fallen by 98.20%
- Appendix 3B 7 May 2018 3:45PM $0.600 $0.010 fallen by 98.33%
- Appendix 4C - quarterly 30 Apr 2018 10:25AM $0.580 $0.010 fallen by 98.28%
- Appendix 3B 20 Apr 2018 3:44PM $0.620 $0.010 fallen by 98.39%
- Bionomics Presents BNC101 and BNC105 Data at AACR Conference 13 Apr 2018 10:33AM $0.585 $0.010 fallen by 98.29%
- Phase 2 PTSD Clinical Trial Fully Recruited 11 Apr 2018 9:51AM $0.540 $0.010 fallen by 98.15%

326 - 350 of 801 results

Page 14 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.